HAVCR2 and neoplasm: Further analyses showed that the combination treatment elevated PD-1, LAG3, TIM-3, and CTLA-4 expression in bulk tumor samples, a pattern most consistent with increased T-cell infiltration and activation (Fig. S4A–D).